Home > Qtrly Results > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Quarterly Results Analysis [Jun2026]

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
Audited
Sep2024
Audited
Revenues ₹328 Cr ₹52 Cr ₹66 Cr ₹44 Cr ₹284 Cr ₹52 Cr ₹37 Cr ₹32 Cr
Expenses ₹293 Cr ₹47 Cr ₹62 Cr ₹38 Cr ₹254 Cr ₹52 Cr ₹29 Cr ₹27 Cr
Operating Income ₹35 Cr ₹4 Cr ₹4 Cr ₹6 Cr ₹29 Cr ₹0 Cr ₹8 Cr ₹5 Cr
Other Income ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹4 Cr ₹0 Cr ₹0 Cr
Interest ₹4 Cr ₹5 Cr ₹5 Cr ₹4 Cr ₹3 Cr ₹1 Cr ₹4 Cr ₹3 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹33 Cr ₹2 Cr ₹2 Cr ₹3 Cr ₹29 Cr ₹2 Cr ₹4 Cr ₹1 Cr
Profit After Tax ₹32 Cr ₹0 Cr ₹2 Cr ₹3 Cr ₹28 Cr ₹1 Cr ₹3 Cr ₹1 Cr
EPS ₹16.98 ₹0.00 ₹0.84 ₹1.45 ₹14.88 ₹0.78 ₹1.39 ₹0.59
Industry Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) 1.5% -2.2% -9.5%
KAVERI SEED COMPANY -2% -13.6% -29.9%
VENKYS (INDIA) 6.1% 11.6% 5.2%
AVT NATURAL PRODUCTS -0.2% 0.8% -1.7%
BOMBAY SUPER HYBRID SEEDS 5.2% -1.2% NA
MANGALAM GLOBAL ENTERPRISE -1.5% -7.2% -12.8%
INDO US BIOTECH -0.7% -6.2% -48.6%
JK AGRI GENETICS -2% -0.3% -19.4%
MANGALAM SEEDS 5.2% 16.7% -18.3%

NATH BIOGENES (INDIA) Quarterly Revenues

Revenues
Q-o-Q

536.53 %

Y-o-Y

15.76 %

Quarters Revenues % Change
Jun2026 ₹328 Cr
536.53
Mar2026 ₹52 Cr
-21.78
Dec2025 ₹66 Cr
50.42
Sep2025 ₹44 Cr
-84.54
Jun2025 ₹284 Cr
445.91
Mar2025 ₹52 Cr
40.94
Dec2024 ₹37 Cr
14.54
Sep2024 ₹32 Cr -

NATH BIOGENES (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

684.95 %

Y-o-Y

20.03 %

Quarters Operating Profit % Change
Jun2026 ₹35 Cr
684.95
Mar2026 ₹4 Cr
25.29
Dec2025 ₹4 Cr
-41.44
Sep2025 ₹6 Cr
-79.16
Jun2025 ₹29 Cr
6,990.56
Mar2025 ₹0 Cr
-94.86
Dec2024 ₹8 Cr
67.01
Sep2024 ₹5 Cr -
Operating Margins
Q-o-Q

23.27 %

Y-o-Y

3.68 %

Quarters Operating Margin% % Change
Jun2026 10.7%
23.27
Mar2026 8.68%
60.15
Dec2025 5.42%
-61.06
Sep2025 13.92%
34.88
Jun2025 10.32%
1,206.33
Mar2025 0.79%
-96.38
Dec2024 21.8%
45.82
Sep2024 14.95% -

NATH BIOGENES (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

14.08 %

Quarters Profit After Tax % Change
Jun2026 ₹32 Cr
Positive
Mar2026 ₹0 Cr
Negative
Dec2025 ₹2 Cr
-41.66
Sep2025 ₹3 Cr
-90.27
Jun2025 ₹28 Cr
2,908.51
Mar2025 ₹1 Cr
-64.54
Dec2024 ₹3 Cr
137.97
Sep2024 ₹1 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

-1.50 %

Quarters PAT Margin(%) % Change
Jun2026 9.82 %
Positive
Mar2026 -0.02 %
Negative
Dec2025 2.43 %
-61.31
Sep2025 6.28 %
-37.01
Jun2025 9.97 %
450.83
Mar2025 1.81 %
-74.83
Dec2024 7.19 %
107.80
Sep2024 3.46 % -

NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

0

Y-o-Y

14.11 %

Quarters EPS % Change
Jun2026 ₹16.98
0
Mar2026 ₹0
-100.00
Dec2025 ₹0.84
-42.07
Sep2025 ₹1.45
-90.26
Jun2025 ₹14.88
1,807.69
Mar2025 ₹0.78
-43.88
Dec2024 ₹1.39
135.59
Sep2024 ₹0.59 -

You may also like the below Video Courses